
Journal Menu
► ▼ Journal Menu-
- Current Oncology Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
Need Help?
Announcements
9 September 2025
Current Oncology | Invitation to Explore the Editor’s Choice Articles
Editor’s Choice Articles are selected based on suggestions from the Academic Editors of Current Oncology (ISSN: 1718-7729). The editors select a small number of published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are therefore invited to read the Editor’s Choice Articles, a curated list of high-quality articles published in Current Oncology. The full list of Editor’s Choice Articles can be viewed via the following link: https://www.mdpi.com/journal/curroncol/editors_choice.
1. “Pediatric Brain Tumours: Lessons from the Immune Microenvironment”
by Betty Yao, Alberto Delaidelli, Hannes Vogel and Poul H. Sorensen
Curr. Oncol. 2023, 30(5), 5024-5046; https://doi.org/10.3390/curroncol30050379
2. “Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma”
by Luisa M. Cardenas, Jasna E. Deluce, Shahrukh Khan, Omar Gulam, Saman Maleki Vareki, Ricardo Fernandes and Aly-Khan A. Lalani
Curr. Oncol. 2022, 29(8), 5426-5441; https://doi.org/10.3390/curroncol29080429
3. “Invasive Fungal Disease in Patients with Chronic Lymphocytic Leukemia in Japan: A Retrospective Database Study”
by Takeo Yasu, Kotono Sakurai and Manabu Akazawa
Curr. Oncol. 2022, 29(5), 3242-3251; https://doi.org/10.3390/curroncol29050264
4. “Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment”
by Mirko Minini and Laura Fouassier
Curr. Oncol. 2023, 30(4), 4185-4196; https://doi.org/10.3390/curroncol30040319
5. “Neurologic Complications of Cancer Immunotherapy”
by Aseel N. Alsalem, Leslie A. Scarffe, Hannah R. Briemberg, Ashley E. Aaroe and Rebecca A. Harrison
Curr. Oncol. 2023, 30(6), 5876-5897; https://doi.org/10.3390/curroncol30060440
6. “Evolution of the Surgical Management of Lung Cancer Invading the Spine: A Single Center Experience”
by Gabrielle Drevet, Théo Broussolle, Yanis Belaroussi, Lucie Duponchelle, Jean Michel Maury, Renaud Grima, Gualter Vaz, Clément Silvestre and François Tronc
Curr. Oncol. 2022, 29(5), 3061-3071; https://doi.org/10.3390/curroncol29050248
7. “X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma”
by Raneem Yaseen Hammouz, Magdalena Orzechowska, Dorota Anusewicz and Andrzej K. Bednarek
Curr. Oncol. 2023, 30(2), 1395-1415; https://doi.org/10.3390/curroncol30020107
8. “Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review”
by Jessie Luo, Nizar J. Bahlis, Denise Chan, Peter Duggan, Victor H. Jimenez-Zepeda, Holly Lee, Sylvia McCulloch, Paola Neri and Jason Tay
Curr. Oncol. 2024, 31(12), 7445-7458; https://doi.org/10.3390/curroncol31120550